-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $465

Benzinga·07/14/2026 15:27:04
Listen to the news
TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $400 to $465.